Removal of opioid/acetaminophen combination prescription pain medications: Assessing the evidence for hepatotoxicity and consequences of removal of these medications

Pain Medicine

Volumn 11, Issue 3, 2010, Pages 369-378

  Michna, Edward ^a,b   Duh, Mei Sheng ^c   Korves, Caroline ^c   Dahl, June L ^d  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c ANALYSIS GROUP   (United States)

^d UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Hydrocodone; Opioids; Oxycodone; Pain management; Safety

Indexed keywords

ACETYLSALICYLIC ACID; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BUPRENORPHINE; FENTANYL; HYDROCODONE; HYDROCODONE BITARTRATE PLUS PARACETAMOL; HYDROMORPHONE; IBUPROFEN; METHADONE; MORPHINE; OPIATE; OXYCODONE; OXYCODONE PLUS PARACETAMOL; PARACETAMOL; TRAMADOL;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; DISEASE SEVERITY; DRUG ABUSE; DRUG FATALITY; DRUG LABELING; DRUG MISUSE; DRUG OVERDOSE; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; EPIDEMIOLOGICAL DATA; FOOD AND DRUG ADMINISTRATION; HEALTH CARE SYSTEM; HUMAN; LIVER DISEASE; LIVER FAILURE; LIVER INJURY; LIVER TOXICITY; MEDICAL DECISION MAKING; OBSERVATIONAL STUDY; PAIN; PATIENT COMPLIANCE; PRESCRIPTION; RECOMMENDED DRUG DOSE; REVIEW; RISK ASSESSMENT; RISK REDUCTION;

EID: 77950969336     PISSN: 15262375     EISSN: 15264637     Source Type: Journal    
DOI: 10.1111/j.1526-4637.2010.00811.x     Document Type: Review

References (34)

1. Smith L. Acetaminophen may get pulled from Rx combo products after narrow vote. 2009, http://thepinksheet.elsevierbi.com/cs/Satellite?c=Page&cid=1216099165884&pagename=FDCReports/Page/PageNavigatorWrapper&autoLogin=yes&queryStr=resultpage*ArticleDetail:ArticleDetailWrapper/pii*00710270015/pubdate*20090706/qbax*sTbB2LA2KomiyWpHughAew==&jid=pink&pii=00710270015&pubdate=20090706, The Pink Sheet. Available at: (accessed July 1, 2009
2. Centers for Disease Control and Prevention Website. 2006, http://www.cdc.gov/nchs/data/hus/hus06.pdf, Health, United States, 2006 with Chartbook in Trends of the Health of Americans, Available at: (accessed October 1, 2009
3. Pharmacological management of persistent pain in older persons. J Am Geriatr Soc 2009, 57:1131-346. American Geriatrics Society Panel on the Pharmacological Management of Persistent Pain in Older Persons
4. The management of persistent pain in older persons. J Am Geriatr Soc 2002, 50:S205-24. American Geriatrics Society Panel on Persistent Pain in Older Persons
5. McCarberg BH, Nicholson BD, Todd KH, Palmer T, Penies L. The impact of pain on quality of life and the unmet needs of pain management: Results from pain sufferers and physicians participating in an internet survey. Am J Ther 2008, 15:312-20.
6. Stewart WF, Ricci JA, Chee E, Morganstein D, Lipton R. Lost productive time and cost due to common pain conditions in the US workforce. JAMA 2003, 290:2443-54.
7. Pain assessment and treatment in the managed care environment. 2000, http://www.ampainsoc.org/advocacy/assess_treat_mce.htm, American Pain Society Website, Available at: (accessed October 1, 2009
8. Wysowski DK, Governale LA, Swann J. Trends in outpatient prescription drug use and related costs in the US 1998-2003. Pharmacoeconomics 2006, 24:233-6.
9. Assessment of the analgesic efficacy and hepatotoxicity of opioid/acetaminophen combination products. March 12, 2007. http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DrugSafetyandRiskManagementAdvisoryCommittee/UCM164898.pdf, FDA Center for Drug Evaluation and Research, US Food and Drug Administration Website. Available at: (accessed August 1, 2009
10. Larson AM, Polson J, Fontana RJ. Acetaminophen-induced acute liver failure: Results of a United States multicenter, prospective study. Hepatology 2005, 42:1364-72.
11. OTC and prescription combination APAP use. November 30, 2006. http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DrugSafetyandRiskManagementAdvisoryCommittee/UCM164898.pdf, US Food and Drug Administration Website. Available at: (accessed August 1, 2009
12. Chun LJ, Tong MJ, Busuttil RW, Hiatt JR. Acetaminophen hepatotoxicity and acute liver failure. J Clin Gastroenterol 2009, 43:342-9.
13. Jover R, Ponsoda X, Gomez-Lechon MJ. Potentiation of cocaine hepatotoxicity by ethanol in human hepatocytes. Toxicol Appl Pharmacol 1991, 107:526-34.
14. Cooper MA. Lightning Safety. http://www.lightningsafety.noaa.gov/medical.htm, National Oceanic and Atmospheric Administration's National Weather Service Website. Available at: (accessed August 1, 2009
15. Bower WA, Johns M, Margolis HS, Williams IT, Bell BP. Population-based surveillance for acute liver failure. Am J Gastroenterol 2007, 102:2459-63.
16. US Food and Drug Administration Website. http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/Surveillance/AdverseDrugEffects/default.htm, Adverse Event Reporting System (AERS), Available at: (accessed December 1, 2009
17. Watson WA, Litovitz T, Rubin C. Toxic exposure surveillance system. MMWR 2004, 53S:262.
18. Chang YJ, Nourjah P, Ahmad SR, Willy M. Office surveillance and epidemiology safety review: Acetaminophen, hepatotoxicity, overdose and death: February 5, 2007. http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DrugSafetyandRiskManagementAdvisoryCommittee/UCM164898.pdf, US Food and Drug Administration Website. Available at: (accessed August 1, 2009
19. Karwoski CB. Briefing document: Acetaminophen-containing products, hepatotoxicity. August 2, 2002. http://www.fda.gov/ohrms/dockets/ac/02/briefing/3882b1_02_C-Acetaminophen%20Hepatotoxicity.pdf2009, US Food and Drug Administration Website. Available at: (accessed January 26, 2010
20. Nourjah P, Ahmad SR, Karwoski C, Willy M. Estimates of acetaminophen (paracetamol)-associated overdoses in the United States. Pharmacoepidemiol Drug Saf 2005, 15:398-405.
21. Duh MS, Vekeman F, Korves C. Risk of hepatotoxicity-related hospitalizations among patients treated with opioid/acetaminophen combination prescription pain medications. Pain Submitted
22. FDA Advisory Committee Meeting. 2009, Joint meeting of the drug safety and risk management advisory committee with the anesthetic and life support drugs advisory committee and the nonprescription drugs advisory committee meeting, presentation. Bethesda, MD
23. Lanas A, Ferrandez A. NSAID-induced gastrointestinal damage: Current clinical management and recommendations for prevention. Chin J Dig Dis 2006, 7:127-33.
24. Lafrance JP, Miller DR. Selective and non-selective non-steroidal anti-inflammatory drugs and the risk of acute kidney injury. Pharmacoepidemiol Drug Saf 2009, 18:923-31.
25. Singh G. Recent considerations in nonsteroidal anti-inflammatory drug gastropathy. Am J Med 1998, 105:31S-38S.
26. Briefing materials for drug safety and management anesthetic and life support and nonprescription drugs advisory committee meeting. June 29-30, 2009. http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DrugSafetyandRiskManagementAdvisoryCommittee/UCM168778.pdf, McNeil Consumer Healthcare, US Food and Drug Administration Website. Available at: (accessed August 1, 2009
27. Adams EH, Breiner S, Cicero TJ. A comparison of the abuse liability of tramadol, NSAIDs, and hydrocodone in patients with chronic pain. J Pain Symptom Manage 2006, 31:465-76.
28. White A, Birnbaum HG, Mareva MN. Direct costs of opioid abuse in an insured population in the United States. J Manag Care Pharm 2005, 11:469-79.
29. Cicero TJ, Inciardi JA, Munoz A. Trends in abuse of OxyContin and other opioid analgesics in the United States: 2002-2004. J Pain 2005, 6:662-72.
30. Manchikanti L, Singh A. Therapeutic opioids: A ten-year perspective on the complexities and complications of the escalating use, abuse, and nonmedical use of opioids. Pain Physician 2008, 11:S63-88.
31. Schneider MF, Bailey JE, Cicero TJ. Integrating nine prescription opioid analgesics and/or four signal detection systems to summarize statewide prescription drug abuse in the United States in 2007. Pharmacoepidemiol Drug Saf 2009, 18:778-90.
32. Rees J, Moore RA, McQuay HJ, Derry S, Gaskell H. Single dose oral oxycodone and oxycodone plus paracetamol (acetaminophen) for acute postoperative pain in adults. Cochrane Database Syst Rev 2000, (2). Art. No: CD002763, DOI: 10.1002/14651858.CD002763
33. Borgsteede SD, Deliens L, Zuurmond WWA. Prescribing of pain medication in palliative care. A survey in general practice. Pharmacoepidemiol Drug Saf 2009, 18:16-23.
34. Recommendations for FDA interventions to decrease the occurrence of acetaminophen hepatotoxicity. February 26, 2008. http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DrugSafetyandRiskManagementAdvisoryCommittee/UCM164898.pdf, US Food and Drug Administration Website. Available at: (accessed August 1, 2009